Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of the molecular genetics of cancer. Studying germline mutations in BRCA1,...
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
pancreatic cancer cells

Researchers Identify Familial Pancreatic Cancer Gene

Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.
Business people on video conference

Genetic Counseling 2.0

As genetic testing ramps up in the clinic and via consumer-oriented providers, companies leverage technology to scale genetic counseling services.
Human microbiome, conceptual illustration

Genetic Differences in Immune System Influences Makeup of Microbiome

Scientists headed by a team at the University of Chicago have shown how genetic differences in the immune system can impact on the types...
Diabetes mellitus metabolic disease signs and symptoms concept, 3D rendering

Actionable Type 2 Diabetes Risks Uncovered

More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the...
New data describes the economic impact of genomic sequencing procedures. [NIH]

Microsoft, Jackson Labs Collaboration Creates Precision Medicine Database

The collaboration will curate JAX’s Clinical Knowledgebase (CKB), a searchable database where subject matter experts store, sort, and interpret complex genomic and other data that can be used to improve patient outcomes.

Treading with Caution: PGx Test Developers Pursue Dialogue as FDA Maintains Enforcement Stance

Developers of pharmacogenetic tests cheered in August when United Healthcare (UHC) concluded in a policy statement effective October 1, that “the use of pharmacogenetic...

Exact Sciences to Expand Cancer Dx Menu via $2.8B Genomic Health Acquisition

Exact Sciences said today it has agreed to acquire Genomic Health for $2.8 billion in cash and stock, in a deal intended to create...
Extending a collaboration launched last year

Celsee, IncellDx Sign Lung Cancer CTC PD-L1 Agreement

The companies will co-commercialize their respective single-cell technologies for CTCs and PD-L1 expression following positive study results
Owlstone Medical will partner with Renji Hospital in Shanghai to conduct a clinical trial assessing the company's Breath Biopsy diagnostic breathalyzer platform in early detection of lung cancer

Owlstone Medical, Thermo Fisher Forge Breath Biopsy Technology Collaboration

The collaboration will integrate Thermo Fisher’s Orbitrap gas chromatography mass spectrometry (GC-MS) instrumentation into Owlstone’s breath biopsy platform to conduct metabolomics studies for unique biomarkers.

PredictImmune Partners with Foundation on Study to Validate IBD Test

The test stratifies patients based on their risk of subsequently experiencing a severe disease course, which is characterized by the requirement for multiple escalations in treatment due to frequently relapsing or chronically active disease.

2020 Vision: Industry Leaders Share Predictions of What May Shape Precision Medicine in the...

As 2020 approaches, it is fair to say that significant—and perhaps surprising—advances will be made in the precision medicine and omics arenas, as there...

Promega to Develop MSI Technology as CDx to Merck’s Keytruda

Promega’s MSI testing is designed to functionally measure the genomic accumulation of insertion or deletion (INDEL) errors caused by a deficient mismatch-repair system (dMMR) that occurs in certain types of solid tumors.
Alzheimers disease, illustration

APOE Gene Variant Makes Some Resistant to Alzheimer’s Onset

Researchers have identified a rare mutation in the APOE3 gene which could help to explain why some people are more resistant to the neurodegenerative disease than others.
Scroll Up